Publications

Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the Mipra Trial

AuthID
P-015-D05

Author(s)

Elía, A

Saldain, L

Vanzulli, SI

Helguero, LA

Lamb, CA

Fabris, V

Pataccini, G

Martínez-Vazquez, P

Burruchaga, J

Caillet-Bois, I

[+4]·

Lovisi, S

Abascal, MF

Novaro, V

Sánchez, J

Muñoz, J

Belizán, JM

Abba, MC

Gass, H

Rojas, P

Lanari, C

View all authors

Document Type

Article

Year published

2022

Published

in Clinical Cancer Research, ISSN: 1078-0432

Volume: 29, Issue: 5, Pages: 866-877

Indexing

Crossref^®14

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1158/1078-0432.ccr-22-2060

Source Identifiers

ISSN: 1078-0432

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Name	Name Order	Name	Name Order	Name
1	Elía, A;	2	Saldain, L;	3	Vanzulli, SI;
4	Helguero, LA;	5	Lamb, CA;	6	Fabris, V;
7	Pataccini, G;	8	Martínez-Vazquez, P;	9	Burruchaga, J;
10	Caillet-Bois, I;	11	Spengler, E;	12	Acosta Haab, G;
13	Liguori, M;	14	Castets, A;	15	Lovisi, S;
16	Abascal, MF;	17	Novaro, V;	18	Sánchez, J;
19	Muñoz, J;	20	Belizán, JM;	21	Abba, MC;
22	Gass, H;	23	Rojas, P;	24	Lanari, C;

Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the Mipra Trial

Useful Links

Get Help

Federated Authentication (Click on the image)

Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the Mipra Trial

Useful Links

Get Help